Download Report
Despite parallel efforts by biopharmaceutical innovators, the demographics of clinical trials today still do not reflect the racial, ethnic or gender diversity of target patient populations around the world. As advanced health systems around the world enter an era of genomic and precision medicine, lack of diversity across the clinical research landscape is a daunting obstacle.
This report describes some of the strategies different stakeholders employ to address a diversity deficit, along with their insights and experiences on the front lines of this endeavor.
